Angio-adaptation in unloaded skeletal muscle: New insights into an early and muscle type-specific dynamic process

Journal of Physiology

Volumn 588, Issue 22, 2010, Pages 4579-4591

  Roudier, Emilie ^a   Gineste, Charlotte ^a,b   Wazna, Alexandra ^a   Dehghan, Kooroush ^a   Desplanches, Dominique ^b   Birot, Olivier ^a  

^a York University   (Canada)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDM2; PROTEIN P53; THROMBOSPONDIN 1; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FEMALE; HEMODYNAMICS; HINDLIMB; MUSCLE ATROPHY; NONHUMAN; PLANTARIS MUSCLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SOLEUS MUSCLE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CAPILLARIES; FEMALE; HINDLIMB SUSPENSION; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, WISTAR;

EID: 78449233806     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2010.193243     Document Type: Article

References (53)

1. Alway SE, Lowe DA & Chen KD (2001). The effects of age and hindlimb supension on the levels of expression of the myogenic regulatory factors MyoD and myogenin in rat fast and slow skeletal muscles. Exp Physiol 86, 509-517.
2. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV & Neckers LM (1998). Stabilization of wild-type p53 by hypoxia-inducible factor 1α. Nature 392, 405-408.
3. Bellomo D, Headrick JP, Silins GU, Paterson CA, Thomas PS, Gartside M, Mould A, Cahill MM, Tonks ID, Grimmond SM, Townson S, Wells C, Little M, Cummings MC, Hayward NK & Kay GF (2000). Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res 86, E29-35.
4. Blagosklonny MV, Giannakakou P, Wojtowicz M, Romanova LY, Ain KB, Bates SE & Fojo T (1998). Effects of p53-expressing adenovirus on the chemosensitivity and differentiation of anaplastic thyroid cancer cells. J Clin Endocrinol Metab 83, 2516-2522.
5. Booth FW & Thomason DB (1991). Molecular and cellular adaptation of muscle in response to exercise: perspectives of various models. Physiol Rev 71, 541-585.
6. Breen EC (2007). VEGF in biological control. J Cell Biochem 102, 1358-1367.
7. Brown MD & Hudlicka O (2003). Modulation of physiological angiogenesis in skeletal muscle by mechanical forces: involvement of VEGF and metalloproteinases. Angiogenesis 6, 1-14.
8. Bryan BA, Walshe TE, Mitchell DC, Havumaki JS, Saint-Geniez M, Maharaj AS, Maldonado AE & D'Amore PA (2008). Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation. Mol Biol Cell 19, 994-1006.
9. Carson JA, Nettleton D & Reecy JM (2002). Differential gene expression in the rat soleus muscle during early work overload-induced hypertrophy. FASEB J 16, 207-209.
10. Claesson-Welsh L (2008). VEGF-B taken to our hearts: specific effect of VEGF-B in myocardial ischemia. Arterioscler Thromb Vasc Biol 28, 1575-1576.
11. Dameron KM, Volpert OV, Tainsky MA & Bouck N (1994). Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 5178, 1582-1584.
12. Däpp C, Schmutz S, Hoppeler H & Flück M (2004). Transcriptional reprogramming and ultrastructure during atrophy and recovery of mouse soleus muscle. Physiol Genomics 20, 97-107.
13. Degens H, Moore JA & Alway SE (2003). Vascular endothelial growth factor, capillarization, and function of the rat plantaris muscle at the onset of hypertrophy. Jpn J Physiol 53, 181-191.
14. Desplanches D, Mayet MH, Sempore B & Flandrois R (1987). Structural and functional responses to prolonged hindlimb suspension in rat muscle. J Appl Physiol 63, 558-563.
15. Egginton S (2009). Invited review: activity-induced angiogenesis. Pflugers Arch 457, 963-977.
16. Eischen CM & Lozano G (2009). p53 and MDM2: antagonists or partners in crime? Cancer Cell 15, 161-162.
17. Ferrara N (2009). Vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 29, 789-791.
18. Flück M, Schmutz S, Wittwer M, Hoppeler H & Desplanches D (2005). Transcriptional reprogramming during reloading of atrophied rat soleus muscle. Am J Physiol Regul Integr Comp Physiol 289, R4-14.
19. Fujino H, Kohzuki H, Takeda I, Kiyooka T, Miyasaka T, Mohri S, Shimizu J & Kajiya F (2005). Regression of capillary network in atrophied soleus muscle induced by hindlimb unweighting. J Appl Physiol 98, 1407-1413.
20. Hagberg CE, Falkevall A, Wang X, Larsson E, Huusko J, Nilsson I, Van Meeteren LA, Samen E, Lu L, Vanwildemeersch M, Klar J, Genove G, Pietras K, Stone-Elander S, Claesson-Welsh L, Ylä-Herttuala S, Lindahl P & Eriksson U (2010). Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature 464, 917-921.
21. Hudlicka O, Brown M & Egginton S (1992). Angiogenesis in skeletal and cardiac muscle. Physiol Rev 72, 369-417.
22. Hudlicka O & Brown MD (2009). Adaptation of skeletal muscle microvasculature to increased or decreased blood flow: role of shear stress, nitric oxide and vascular endothelial growth factor. J Vasc Res 46, 504-512.
23. Hyatt JP, McCall GE, Kander EM, Zhong H, Roy RR & Huey KA (2008). PAX3/7 expression coincides with MyoD during chronic skeletal muscle overload. Muscle Nerve 38, 861-866.
24. Kano Y, Shimegi S, Takahashi H, Masuda K & Katsuta S (2000). Changes in capillary luminal diameter in rat soleus muscle after hind-limb suspension. Acta Physiol Scand 169, 271-276.
25. Li X (2010). VEGF-B: a thing of beauty. Cell Res 20, 741-744.
26. Li Y, Zhang F, Nagai N, Tang Z, Zhang S, Scotney P, Lennartsson J, Zhu C, Qu Y, Fang C, Hua J, Matsuo O, Fong GH, Ding H, Cao Y, Becker KG, Nash A, Heldin CH & Li X (2008). VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. J Clin Invest 118, 913-923.
27. McDonald KS, Delp MD & Fitts RH (1992a). Fatigability and blood flow in the rat gastrocnemius-plantaris-soleus after hindlimb suspension. J Appl Physiol 73, 1135-1140.
28. McDonald KS, Delp MD & Fitts RH (1992b). Effect of hindlimb unweighting on tissue blood flow in the rat. J Appl Physiol 72, 2210-2218.
29. Machida S & Booth FW (2004). Regrowth of skeletal muscle atrophied from inactivity. Med Sci Sports Exerc 36, 52-59.
30. Malek MH & Olfert IM (2009). Global deletion of thrombospondin-1 increases cardiac and skeletal muscle capillarity and exercise capacity in mice. Exp Physiol 94, 749-760.
31. Malek MH, Olfert IM & Esposito F (2010). Detraining losses of skeletal muscle capillarization are associated with vascular endothelial growth factor protein expression in rats. Exp Physiol 95, 359-368.
32. Milkiewicz M, Hudlicka O, Shiner R, Egginton S & Brown MD (2006). Vascular endothelial growth factor mRNA and protein do not change in parallel during non-inflammatory skeletal muscle ischaemia in rat. J Physiol 577, 671-678.
33. Morey-Holton ER & Globus RK (2002). Hindlimb unloading rodent model: technical aspects. J Appl Physiol 92, 1367-1377.
34. Mozdziak PE, Greaser ML & Schultz E (1998). Myogenin, MyoD, and myosin expression after pharmacologically and surgically induced hypertrophy. J Appl Physiol 84, 1359-1364.
35. Olfert IM, Breen EC, Gavin TP & Wagner PD (2006). Temporal thrombospondin-1 mRNA response in skeletal muscle exposed to acute and chronic exercise. Growth Factors 24, 253-259.
36. Olfert IM, Howlett RA, Tang K, Dalton ND, Gu Y, Peterson KL, Wagner PD & Breen EC (2009). Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice. J Physiol 587, 1755-1767.
37. Olofsson B, Pajusola K, Kaipainen A, Von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K & Eriksson U (1996a). Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A 93, 2576-2581.
38. Olofsson B, Pajusola K, Von Euler G, Chilov D, Alitalo K & Eriksson U (1996b). Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J Biol Chem 271, 19310-19317.
39. Pal S, Datta K & Mukhopadhyay D (2001). Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma. Cancer Res 61, 6952-6957.
40. Parvaresh K, Huber A, Brochin R, Bacon P, McCall G, Huey K & Hyatt JP (2010). Acute VEGF expression during hypertrophy is muscle phenotype-specific and localizes as a striated pattern within fibers. Exp Physiol (in press).
41. Prior BM, Yang HT & Terjung RL (2004). What makes vessels grow with exercise training J Appl Physiol 97, 1119-1128.
42. Qin XQ, Livingston DM, Kaelin WG Jr & Adams PD (1994). Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc Natl Acad Sci U S A 91, 10918-10922.
43. Ravi R, Mookerjee B, Bhujwalla ZM, Sutter CH, Artemov D, Zeng Q, Dillehay LE, Madan A, Semenza GL & Bedi A (2000). Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev 14, 34-44.
44. Ren B, Yee KO, Lawler J & Khosravi-Far R (2006). Regulation of tumor angiogenesis by thrombospondin-1. Biochim Biophys Acta 1765, 178-188.
45. Roudier E, Chapados N, Decary S, Gineste C, Le Bel C, Lavoie JM, Bergeron R & Birot O (2009). Angiomotin p80/p130 ratio: a new indicator of exercise-induced angiogenic activity in skeletal muscles from obese and non-obese rats J Physiol 587, 4105-4119.
46. Silvestre JS, Tamarat R, Ebrahimian TG, Le-Roux A, Clergue M, Emmanuel F, Duriez M, Schwartz B, Branellec D & Lévy BI (2003). Vascular endothelial growth factor-B promotes in vivo angiogenesis. Circ Res 93, 114-123.
47. Siu PM, Pistilli EE, Murlasits Z & Alway SE (2006). Hindlimb unloading increases muscle content of cytosolic but not nuclear Id2 and p53 proteins in young adult and aged rats. J Appl Physiol 100, 907-916.
48. Su F, Pascal LE, Xiao W & Wang Z (2010). Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53. Oncogene 29, 421-431.
49. Tang K, Breen EC, Gerber HP, Ferrara NM & Wagner PD (2004). Capillary regression in vascular endothelial growth factor-deficient skeletal muscle. Physiol Genomics 18, 63-69.
50. Vousden KH & Prives C (2009). Blinded by the light: The growing complexity of p53. Cell 137, 413-431.
51. Wagatsuma A (2008). Effect of hindlimb unweighting on expression of hypoxia-inducible factor-1α vascular endothelial growth factor, angiopoietin, and their receptors in mouse skeletal muscle. Physiol Res 57, 613-620.
52. Williams JL, Weichert A, Zakrzewicz A, Da Silva-Azevedo L, Pries AR, Baum O & Egginton S (2006a). Differential gene and protein expression in abluminal sprouting and intraluminal splitting forms of angiogenesis. Clin Sci (Lond) 110, 587-595.
53. Williams JL, Cartland D, Rudge JS & Egginton S (2006b). VEGF trap abolishes shear stress- and overload-dependent angiogenesis in skeletal muscle. Microcirculation 13, 499-509.